Newsom Signs New Election Codes Into Law Ahead Of Statewide Primary

A flurry of bad news has drawn fresh scrutiny to the roughly $2 tln private credit market, as investors question the health of loan portfolios.

GLP-1 Feud Ends: NOVO, HIMS Join Forces (Again) To Sell Obesity Drugs The epic, months-long GLP-1 feud between Novo Nordisk and telehealth firm Hims & Hers Health appears to be coming to a surprising end, with both companies reportedly set to announce, as soon as Monday, a new partnership that would allow the Danish drugmaker to sell Wegovy through HIMS' platform. Bloomberg published the report late Friday, stating: Novo Nordisk A/S plans to sell its weight-loss drugs on Hims & Hers Health Inc.'s platform, according to a person familiar with the matter... ... Novo...

China's Unitree Robotics IPO 5,526 Times Oversubscribed By Retail Investors Unitree Robotics' initial public offering was heavily oversubscribed (5,526 times) by retail investors as China's first publicly traded humanoid robotics company prepares to enter the public markets. The IPO will help usher in physical AI to the equity market. The Hangzhou-based humanoid robot maker raised about 6.1 billion yuan, or $904 million, after selling 40.4 million shares at 150.8 yuan each, according to Bloomberg. The offering values Unitree at roughly 61 billion yuan, or $9 billion, ahead of its expected STAR Market debut...